Author Guidelines

Contents

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing Your Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

New submissions should be made via the Research Exchange submission portal. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected]

Data protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com.bibliotheek.ehb.be/statements/data-protection-policy.html.

Preprint policy
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, medRxiv etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
For help with submissions, please contact the editorial office at [email protected].

2. AIMS AND SCOPE

Neurogastroenterology & Motility only accepts submission at http://mc.manuscriptcentral.com/nmo. This enables rapid and effective peer review. Contributions will be acknowledged automatically by the editors and assigned a unique manuscript number that must be quoted in correspondence. Papers and Reviews are refereed by experts in the field; the Editors reserve the right to reject an article without review.

Full uploading instructions and support are available online from the submission site via the “Get Help Now” button. Please submit your covering letter or comments to the editor as well as the names of potential referees when prompted online.

Manuscripts that do not meet the formal criteria listed below will be returned for reformatting, which will delay the review process and possible acceptance. Exceptions to these guidelines may be made in certain circumstances, at the discretion of the Editors. If you require an exemption, please indicate this in your cover letter.

Over the past few years, Neurogastroenterology & Motility has become one of the leading journals in the field of gastroenterology and related areas of physiology. This is reflected by the steadily increasing number of high-quality manuscripts submitted to the Journal. The length of a manuscript needs to be closely adhered to, with any additional material to be published as supporting information. Authors need not pay for the publication of figures in colour.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Article types

Original Articles
Original Articles describe the results of basic or clinical studies, clinical trials or significant Case Reports. The length of an Original Article should be no longer than 5000 words, excluding acknowledgements and disclosures, references, tables, figures, table legends and figure legends, and to limit the number of figures and tables to a maximum of eight in the regular edition of the Journal (e.g. five figures and three tables) in normal circumstances, with any additional material to be published as supporting information.

We work together with Wiley’s open access journal, Clinical Case Reports, to enable rapid publication of good quality case reports that we are unable to accept for publication in our journal. Authors of case reports rejected by our journal will be offered the option of having their case report, along with any related peer reviews, automatically transferred for consideration by the Clinical Case Reports editorial team. Authors will not need to reformat or rewrite their manuscript at this stage, and publication decisions will be made a short time after the transfer takes place. Clinical Case Reports will consider case reports from every clinical discipline and may include clinical images or clinical videos. Clinical Case Reports is an open access journal, and article publication fees apply. For more information please go to www.clinicalcasesjournal.com.

Review Articles
Topical reviews of basic or clinical areas are commissioned by the Reviews Editor. Review Articles are focused topical accounts that highlight new and/or controversial areas. Manuscript length is limited to 5000 words. All Review articles are subject to review by experienced referees. The Journal welcomes un-solicited Reviews, but the Reviews Editor reserves the right to reject these without formal review. As Reviews are commissioned by the Editors far in advance of publication, if you wish to submit a non-commissioned review please contact the Reviews Editor, Maura Corsetti ([email protected]) for consideration.

Letters to the Editor
Letters to the Editor offer opinions on papers published in Neurogastroenterology & Motility. Text should not exceed 400 words. Letters commenting on papers are sent to the authors of those papers for a response. Letters are selected for their importance, relevance, and originality; not all letters submitted can be published.

Technical Notes
Technical Notes papers are restricted to a maximum of 1500 words. The manuscript should focus on technique, validation of the technique, and include relevant references and up to two figures.

Book Reviews
Neurogastroenterology & Motility does not publish Book Reviews.

Revisions

To make it easier for re-review, we encourage authors to make the revisions in their manuscript using a colored font (blue or red) and/or a colored highlighter (yellow). They should also provide a point-by-point response to the editor of the changes that were made in a letter that describes the requested change and the responses.

The editors have designated two types of revision for manuscripts in the Journal: (i) Minor revisions: these in general require only changes to the manuscript or easily conducted experiments. Revised manuscripts must be submitted in their final form no later than four weeks of receipt of a revision letter from the Editor. (ii) Major revisions: these require changes to the manuscript and significant additional experiments. Revised manuscripts must be submitted in their final form within three months of receipt of a revision letter from the editor.

In all cases, resubmissions after the allotted time will be considered as new submissions.

Language

Please note that the Journal uses American spelling (e.g. 'esophagus', not 'oesophagus'). Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com.bibliotheek.ehb.be/bauthor/english_language.asp. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication. Authors of manuscripts with a poor standard of English will be directed towards the abovementioned editing services.

4. PREPARING YOUR SUBMISSION

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) format.

Your main document file should include:

1. A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's Wiley's best practice SEO tips);

          A short running title of less than 40 characters;

• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract structured (intro/methods/results/conclusion) or unstructured
• Up to seven keywords;
• Key Points  Authors will need to provide no more than 3 ‘key points’, written with the lay-person in mind, that summarize the key messages of their paper to be published with their article.
• Main body: formatted as introduction, materials & methods, results, discussion, conclusion
• References;
• Tables (each table complete with title and footnotes);
• Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.
• Graphical Abstract;
• Appendices (if relevant).

Cover Letters
A covering letter must be included, signed by the corresponding author and stating on behalf of all the authors that the work has not been published and is not being considered for publication elsewhere.

Parts of the Manuscript
The manuscript should be double-spaced with 30mm margins. Manuscripts must be numbered consecutively in the following sequence: Title Page; Abstract, if required; Main Body of Text; Acknowledgement; Reference List; Tables and Figure caption List.

2. A short informative title containing the major key words. The title should not contain abbreviations

Figures and supporting information should be supplied as separate files.

Title page
On the title page, provide the complete title and a running title (not to exceed 40 characters and spaces). List each contributor's name and institutional affiliation. Provide the name, postal and e-mail address and telephone number of the contributor responsible for the manuscript and proofs. This is the person to whom all correspondence will be sent. The corresponding author is responsible for keeping the editorial office updated with any change in details until the paper is published.

Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract and Keywords
The abstract must not exceed 250 words. It should summarize the aim of the study and describe the work undertaken, results and conclusions. For Original Articles and Technical Notes, the abstract should be structured under four subheadings: Background, Methods, Key Results and Conclusions & Inferences. For Review Articles, the abstract should be structured under Background and Purpose. For Mini-review editorials, “Hot Topics” and Case Reports, the abstract should be unstructured, i.e. without the subheadings. In addition, you should list up to six keywords in alphabetical order. For ideas on optimising your abstract, see here.

Graphical Abstract
A graphical summary is required for all original articles. It is recommended that the graphical summary is provided during the initial submission and is required during the revision stage. Please note that all accepted original articles must include a graphical summary before publication. Wiley Editing Services offers expert help with graphical abstract design if desired.

Keywords
Please provide 5-7 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.

Main body of text
Manuscripts should be typed in a standard, easy to read font, either 11 or 12pt in size. Manuscripts should be double-spaced, with 2.5cm (1 inch) margins on all sides and run in one single column. Please ensure that you have turned “track changes off” and removed any reviewing notes from your manuscripts else these will be visible throughout the review process. Place the page number and first author's last name in the upper right-hand corner of each page.

Review articles should be divided onto the following sections and appear in the following order: (1) title page (with short running page heading, title, authors names and affiliations), (2) abstract and keywords, (3) body of the article, (4) acknowledgments, funding, and disclosures; (5) references, (6) tables, (7) figure legends, and (8) figures.

Original articles should be divided into the following sections and appear in the following order: (1) title page (with short running page heading, title, authors names and affiliations) (2) abstract and keywords, (3) introduction, (4) materials and methods, (5) results, (6) discussion, (7) acknowledgments, funding, and disclosures, (8) references, (9) appendices, (10) supporting information, (11) tables, (12) figure legends, and (13) figures.

Methods and Materials
Animal preparation and experimentation should cite the approving governing body. Equipment and apparatus should cite the make and model number and the company name and address (town, state/city, country) at first mention.

Give all measurements in metric units and use negative indexing (mg mL^–1, not mg/mL). Use generic names of drugs. Symbols, units and abbreviations should be expressed as Système International (SI) units. In exceptional circumstances, others may be used, provided they are consistent. If necessary, please contact the editorial office for further advice.

Experimental Methods Reporting Checklist for Authors

Research design and statistical considerations
Three elements of any study that should be reported explicitly are the hypotheses or research questions being addressed by the research, the design of the study and how the data are statistically analysed. If the paper reports the results of statistical hypothesis tests, then either an a priori (prospective) sample size calculation or a retrospective calculation of statistical power should be given. It is important for readers to understand whether the study had a large enough sample size to achieve its aim. There are many good papers on sample size calculation such as that by Lachin¹ and freely available websites (e.g., sealed envelope) that will undertake the calculations although the journal does not endorse any particular website.

Statistical reporting
Good practice in reporting requires descriptive statistics (numerical and/or graphical) for individual quantitative and qualitative variables as well as measures of effect size when reporting on hypotheses or research questions. When reporting descriptive statistics please remember to include measures of variation, such as standard deviation or interquartile range. When reporting on effect sizes (difference between means, regression slopes, etc.) please remember to include some measure of uncertainty around the effect size estimate in the sample (e.g., confidence intervals).

The journal does not require authors to complete and upload reporting checklists but it does urge authors to be familiar with and comply with reporting standards such as CONSORT for clinical trials (https://www.equator-network.org/reporting-guidelines/consort/), STROBE for observational studies (https://www.equator-network.org/reporting-guidelines/strobe/) and STARD for diagnostic studies (https://www.equator-network.org/reporting-guidelines/stard/). An extensive list of reporting guidelines is available at the equator network (https://www.equator-network.org).

Use of statistical hypothesis tests (p-values)

Statistical hypothesis tests play a key role in evaluating interventions in medical research and, as the name implies, testing hypotheses developed by researchers. However, the probability basis of hypothesis tests assumes that hypotheses are developed 1) a priori (before seeing the data) and 2) that a single hypothesis is being tested. Numerous papers have commented on the problems that ensue from violation of these assumptions^2,3, including one published in this journal⁴.

The journal therefore recommends authors to use and interpret statistical hypothesis tests as intended by following these guidelines:

• Ideally, only report p-values for a priori hypotheses, all else can be reported as effect size with confidence intervals. The confidence interval can be used to comment on whether the data tend to support a particular effect, or not.
• Comment on effect size as much as statistical significance, do not conflate statistical and clinical significance.
• Consider and comment on statistical power when findings are negative
• If multiple statistical hypothesis tests are reported, either account for multiple tests in determining statistical significance or declare the study to be exploratory and in need of replication before its findings can be considered definitive.

References

1. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Controlled clinical trials 1981; 2(2): 93-113.
2. Kennedy-Shaffer L. Before p < 0.05 to Beyond p < 0.05: Using History to Contextualize p-Values and Significance Testing. Am Stat 2019; 73(Suppl 1): 82-90.
3. Wasserstein RL, Lazar NA. The ASA's Statement on p-Values: Context, Process, and Purpose. The American Statistician 2016; 70(2): 129-33.
4. Bangdiwala SI. When to p and when not to p. Neurogastroenterology & Motility 2023; 35(11): e14672.

References
All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:

Journal article:

1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book:

2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.

For more information about AMA reference style -  AMA Manual of Style. 

Endnotes
Endnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep endnotes brief; they should contain only short comments tangential to the main argument of the paper.

Footnotes
Footnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep footnotes brief; they should contain only short comments tangential to the main argument of the paper and should not include references.

Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Data Citation
In recognition of the significance of data as an output of research effort, Wiley has endorsed In recognition of the significance of data as an output of research effort, Wiley has endorsed the FORCE11 Data Citation Principles and is implementing a mandatory data citation policy. Wiley journals require data to be cited in the same way as article, book, and web citations and authors are required to include data citations as part of their reference list.

Data citation is appropriate for data held within institutional, subject focused, or more general data repositories. It is not intended to take the place of community standards such as in-line citation of GenBank accession codes.

When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and in addition provide a formal citation in the reference list. We recommend the format proposed by the Joint Declaration of Data Citation Principles:

• [dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)

Additional Files

Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information
Supporting information is information that is not essential to the article but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points
The following points provide general advice on formatting and style.

• Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly, and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
• Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
• Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
• Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, we encourage authors to consult Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.     

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Papers will only be sent to review if the Editor-in-Chief determine that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on confidentiality of the review process is available here.

Refer and Transfer Program 
Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Guidelines on Publishing and Research Ethics in Journal Articles Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.

Species Names
Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see http://varnomen.hgvs.org/, where examples of acceptable nomenclature are provided.

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

• DNA Data Bank of Japan (DDBJ) www.ddbj.nig.ac.jp
• EMBL Nucleotide Archive: ebi.ac.uk/ena
• GenBank www.ncbi.nlm.nih.gov/genbank

Proteins sequence data should be submitted to either of the following repositories:

• Protein Information Resource (PIR): pir.georgetown.edu
• SWISS-PROT: expasy.ch/sprot/sprot-top

Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: http://www.crossref.org/fundingdata/registry.html

Authorship
The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Data Citation
Please also cite the data you have shared, like you would cite other sources that your article refers to, in your references section. You should follow the format for your data citations laid out in the Joint Declaration of Data Citation Principles, https://www.force11.org/datacitationprinciples:

• [dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)

Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.

Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

ORCID
As part of our commitment to supporting authors at every step of the publishing process, Cytopathology requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information.

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Neurogastroenterology & Motility will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Author Name Change Policy
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

6. AUTHOR LICENSING

If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under open access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: If you choose to publish open access you will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production
When your accepted article is received by Wiley’s production team, you (corresponding author) will receive an email asking you to login or register with Author Services. You will be asked to sign a publication license at this point.

Accepted Articles
The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After publication of the final version article (the article of record), the DOI remains valid and can continue to be used to cite and access the article.
Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is correct for indexing. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.

Proofs
Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.
Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Publication Charges

Accepted Articles
This journal offers rapid publication via Wiley's Accepted Articles Service. Accepted Articles are published on Wiley Online Library within 5 days of receipt, without waiting for a copyright agreement (they are protected under a general copyright statement).

Early View The journal offers rapid publication via Wiley’s Early View service. Early View(Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Before we can publish an article, we require a signed license (authors should login or register with Wiley Author Services. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

Citing this Article: eLocators
This journal now uses eLocators. eLocators are unique identifies for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

8. POST PUBLICATION

Access and sharing
When your article is published online:

• The author receives an email alert (if requested).
• The link to the published article can be shared through social media.
• The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
• For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Measuring the Impact of your Work
Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

Archiving Services
Portico and CLOCKSS are digital archiving/preservation services we use to ensure that Wiley content will be accessible to customers in the event of a catastrophic event such as Wiley going out of business or the platform not being accessible for a significant period of time. Member libraries participating in these services will be able to access content after such an event. Wiley has licenses with both Portico and CLOCKSS, and all journal content gets delivered to both services as it is published on Wiley Online Library. Depending on their integration mechanisms, and volume loads, there is always a delay between content being delivered and showing as “preserved” in these products.

9. EDITORIAL OFFICE CONTACT DETAILS

For queries about submissions, please contact the editorial office at [email protected].